Regeneron Pharmaceuticals, Inc 10-Q for FY2022 Q3
Regeneron Pharmaceuticals, Inc. (REGN)
10-Q
2022-11-03
For: 2022-09-30
View Original
Added on
April 08, 2026
About this 10-Q
Regeneron Pharmaceuticals, Inc filed this 10-Q on November 3, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.94B
- down 15.0% from $3.45B a year earlier
- Net income
- $1.32B
- down 19.4% from net income of $1.63B a year earlier
- Diluted EPS
- $11.66
- down 18.6% from $14.33 a year earlier